LABSL Stock Overview
Life Science REIT plc (the “Company”) is a closed-ended Real Estate Investment Trust (“REIT”) incorporated in England and Wales on 27 July 2021. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Life Science REIT plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.38 |
| 52 Week High | UK£0.65 |
| 52 Week Low | UK£0.32 |
| Beta | 0.019 |
| 11 Month Change | -8.50% |
| 3 Month Change | 12.35% |
| 1 Year Change | -41.23% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| LABSL | GB Health Care REITs | GB Market | |
|---|---|---|---|
| 7D | -6.1% | -0.2% | 1.7% |
| 1Y | -41.2% | -9.8% | 8.4% |
Return vs Industry: LABSL underperformed the UK Health Care REITs industry which returned -9.8% over the past year.
Return vs Market: LABSL underperformed the UK Market which returned 8.4% over the past year.
Price Volatility
| LABSL volatility | |
|---|---|
| LABSL Average Weekly Movement | 5.5% |
| Health Care REITs Industry Average Movement | 2.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: LABSL has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: LABSL's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Simon Farnsworth | www.lifesciencereit.co.uk |
Life Science REIT plc (the “Company”) is a closed-ended Real Estate Investment Trust (“REIT”) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange. The registered office of the Company is located at 6th Floor, 65 Gresham Street, London, EC2V 7NQ.
Life Science REIT plc Fundamentals Summary
| LABSL fundamental statistics | |
|---|---|
| Market cap | UK£134.40m |
| Earnings (TTM) | -UK£40.04m |
| Revenue (TTM) | UK£20.12m |
6.7x
P/S Ratio-3.4x
P/E RatioIs LABSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LABSL income statement (TTM) | |
|---|---|
| Revenue | UK£20.12m |
| Cost of Revenue | UK£5.61m |
| Gross Profit | UK£14.51m |
| Other Expenses | UK£54.55m |
| Earnings | -UK£40.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 72.13% |
| Net Profit Margin | -198.99% |
| Debt/Equity Ratio | 44.2% |
How did LABSL perform over the long term?
See historical performance and comparison